Status:
UNKNOWN
Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Breathe BioMedical Inc
Conditions:
SARS-CoV-2 Infection
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
To analyze Volatile Organic Compounds (VOCs) in the breath of patients with SARS-CoV-2 and controls in SARS-CoV-2 breath specimens.
Detailed Description
The study is a prospective cohort study, which enrol patients presenting to hospital and are tested for SARS-CoV-2. There will be two cohorts, COVID-19 positive and COVID-19 negative, who will have ex...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Covid-19 positive patients:
- Clinically tested for SARS-CoV-2 (as completed by standard laboratory testing e.g. RT-PCR) with a positive result
- Clinical features in keeping with COVID-19 illness.
- Inclusion criteria for Covid-19 negative patients:
- Negative RT-PCR COVID-19 test
- Without any clinical features to suggest COVID-19 illness.
- No known or current features of respiratory infection, COPD, asthma, interstitial lung disease, other respiratory inflammatory conditions or lung cancer.
- Able to provide a breath sample (as based on clinical judgement).
- Exclusion Criteria for Covid-19 positive and negative patients:
- \- Unable to provide a breath sample
Exclusion
Key Trial Info
Start Date :
February 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04867213
Start Date
February 15 2021
End Date
March 31 2022
Last Update
April 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences
Hamilton, Ontario, Canada, L8L 0A4